According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM) is $0.13 B. In 2021 the company made a revenue of $0.13 B an increase over the years 2020 revenue that were of $78.89 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $0.13 B | 4.95% |
2021 | $0.13 B | 65.43% |
2020 | $78.89 M | -13.2% |
2019 | $90.89 M | 15.6% |
2018 | $78.62 M | -15.88% |
2017 | $93.46 M | 3.04% |
2016 | $90.71 M | -2.23% |
2015 | $92.78 M | 53.12% |
2014 | $60.59 M | 115.02% |
2013 | $28.18 M | 8.46% |
2012 | $25.98 M | -23.27% |
2011 | $33.86 M | 1922.88% |
2010 | $1.67 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | $44.16 B | 32,145.75% | ๐บ๐ธ USA |
![]() General Electric GE | $76.55 B | 55,791.07% | ๐บ๐ธ USA |
![]() Illumina ILMN | $4.69 B | 3,330.68% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | $4.56 B | 3,232.95% | ๐บ๐ธ USA |
![]() Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
![]() NanoString Technologies NSTG | $0.13 B | -1.22% | ๐บ๐ธ USA |